| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.10e-04 | 5 | 67 | 2 | GO:0140444 | |
| GeneOntologyBiologicalProcess | actin filament-based transport | 5.07e-06 | 11 | 66 | 3 | GO:0099515 | |
| GeneOntologyBiologicalProcess | nuclear migration along microfilament | 1.01e-05 | 2 | 66 | 2 | GO:0031022 | |
| GeneOntologyBiologicalProcess | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration | 3.02e-05 | 3 | 66 | 2 | GO:0021817 | |
| GeneOntologyBiologicalProcess | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 1.00e-04 | 5 | 66 | 2 | GO:0021815 | |
| GeneOntologyBiologicalProcess | nuclear migration along microtubule | 1.00e-04 | 5 | 66 | 2 | GO:0030473 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 1.74e-04 | 34 | 66 | 3 | GO:0007190 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 1.97e-04 | 91 | 66 | 4 | GO:0000794 | |
| GeneOntologyCellularComponent | spectrin | 3.48e-04 | 9 | 66 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 5.30e-04 | 11 | 66 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 5.30e-04 | 11 | 66 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 5.30e-04 | 11 | 66 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 5.30e-04 | 11 | 66 | 2 | GO:0106094 | |
| Domain | PH | 4.24e-07 | 278 | 64 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 4.37e-07 | 279 | 64 | 9 | PS50003 | |
| Domain | PH_domain | 4.51e-07 | 280 | 64 | 9 | IPR001849 | |
| Domain | Spectrin | 1.06e-06 | 23 | 64 | 4 | PF00435 | |
| Domain | PH | 1.11e-06 | 229 | 64 | 8 | PF00169 | |
| Domain | Spectrin_repeat | 2.79e-06 | 29 | 64 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 4.19e-06 | 32 | 64 | 4 | IPR018159 | |
| Domain | SPEC | 4.19e-06 | 32 | 64 | 4 | SM00150 | |
| Domain | - | 7.02e-06 | 391 | 64 | 9 | 2.30.29.30 | |
| Domain | PH_dom-like | 1.39e-05 | 426 | 64 | 9 | IPR011993 | |
| Domain | Actinin_actin-bd_CS | 6.47e-05 | 23 | 64 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 6.47e-05 | 23 | 64 | 3 | PS00020 | |
| Domain | ACTININ_1 | 6.47e-05 | 23 | 64 | 3 | PS00019 | |
| Domain | RhoGEF | 8.66e-05 | 68 | 64 | 4 | SM00325 | |
| Domain | SH3 | 9.57e-05 | 216 | 64 | 6 | SM00326 | |
| Domain | SH3 | 9.57e-05 | 216 | 64 | 6 | PS50002 | |
| Domain | RhoGEF | 9.70e-05 | 70 | 64 | 4 | PF00621 | |
| Domain | DH_2 | 9.70e-05 | 70 | 64 | 4 | PS50010 | |
| Domain | DH-domain | 1.03e-04 | 71 | 64 | 4 | IPR000219 | |
| Domain | - | 1.03e-04 | 71 | 64 | 4 | 1.20.900.10 | |
| Domain | SH3_domain | 1.06e-04 | 220 | 64 | 6 | IPR001452 | |
| Domain | PH_dom-spectrin-type | 4.10e-04 | 9 | 64 | 2 | IPR001605 | |
| Domain | DH_1 | 1.32e-03 | 63 | 64 | 3 | PS00741 | |
| Domain | CH | 1.44e-03 | 65 | 64 | 3 | SM00033 | |
| Domain | CH | 1.78e-03 | 70 | 64 | 3 | PF00307 | |
| Domain | - | 1.86e-03 | 71 | 64 | 3 | 1.10.418.10 | |
| Domain | CH | 2.01e-03 | 73 | 64 | 3 | PS50021 | |
| Domain | CH-domain | 2.17e-03 | 75 | 64 | 3 | IPR001715 | |
| Domain | CRAL_TRIO | 2.33e-03 | 21 | 64 | 2 | PF00650 | |
| Domain | SH3_1 | 2.42e-03 | 164 | 64 | 4 | PF00018 | |
| Domain | - | 2.79e-03 | 23 | 64 | 2 | 3.40.525.10 | |
| Domain | SEC14 | 3.30e-03 | 25 | 64 | 2 | SM00516 | |
| Domain | CRAL_TRIO | 3.84e-03 | 27 | 64 | 2 | PS50191 | |
| Domain | CRAL-TRIO_dom | 4.13e-03 | 28 | 64 | 2 | IPR001251 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.83e-04 | 175 | 43 | 5 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.31e-04 | 184 | 43 | 5 | M41809 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 3.30e-04 | 439 | 43 | 7 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 3.84e-04 | 450 | 43 | 7 | M27078 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.03e-04 | 10 | 43 | 2 | MM15112 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 5.26e-04 | 52 | 43 | 3 | MM14743 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPHK2 EPS15L1 KALRN MYCBP2 NISCH CARD10 EDC4 SNAPC4 NCLN PLEKHG5 RASSF7 FANCA | 1.19e-06 | 1105 | 67 | 12 | 35748872 |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 35394045 | ||
| Pubmed | Linear arrays of nuclear envelope proteins harness retrograde actin flow for nuclear movement. | 3.66e-06 | 2 | 67 | 2 | 20724637 | |
| Pubmed | Coiled-Coil Domains of SUN Proteins as Intrinsic Dynamic Regulators. | 3.66e-06 | 2 | 67 | 2 | 26688217 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19843581 | ||
| Pubmed | GPC1 SPTBN4 USP31 CRACD EPS15L1 UBA1 KALRN NISCH NGEF EDC4 PLEKHG5 DHX29 | 1.66e-05 | 1431 | 67 | 12 | 37142655 | |
| Pubmed | The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal. | 2.19e-05 | 4 | 67 | 2 | 33686165 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 22555292 | ||
| Pubmed | Coupling of the nucleus and cytoplasm: role of the LINC complex. | 2.19e-05 | 4 | 67 | 2 | 16380439 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 2.19e-05 | 4 | 67 | 2 | 20108321 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 19933576 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 18396275 | ||
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 3.64e-05 | 5 | 67 | 2 | 22632968 | |
| Pubmed | alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus. | 3.92e-05 | 34 | 67 | 3 | 16889989 | |
| Pubmed | Samp1 is a component of TAN lines and is required for nuclear movement. | 5.46e-05 | 6 | 67 | 2 | 22349700 | |
| Pubmed | Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes. | 5.46e-05 | 6 | 67 | 2 | 33058875 | |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 5.49e-05 | 38 | 67 | 3 | 11756498 | |
| Pubmed | 7.63e-05 | 7 | 67 | 2 | 36660824 | ||
| Pubmed | 7.98e-05 | 43 | 67 | 3 | 12376548 | ||
| Pubmed | 9.35e-05 | 963 | 67 | 9 | 28671696 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 9.63e-05 | 1201 | 67 | 10 | 35696571 | |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 1.63e-04 | 10 | 67 | 2 | 28533284 | |
| Pubmed | Nuclear membrane proteins with potential disease links found by subtractive proteomics. | 1.63e-04 | 10 | 67 | 2 | 12958361 | |
| Pubmed | Molecular bases for HOIPINs-mediated inhibition of LUBAC and innate immune responses. | 1.63e-04 | 10 | 67 | 2 | 32246052 | |
| Pubmed | SPTBN4 ATF6 EPS15L1 KALRN MYCBP2 NISCH NGEF PPP1R16B SPOCK2 NCAPH2 | 1.67e-04 | 1285 | 67 | 10 | 35914814 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 1.99e-04 | 11 | 67 | 2 | 17607528 | |
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 23583643 | ||
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 2.16e-04 | 60 | 67 | 3 | 12787561 | |
| Pubmed | Excess LINC complexes impair brain morphogenesis in a mouse model of recessive TOR1A disease. | 2.38e-04 | 12 | 67 | 2 | 29868845 | |
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 21177258 | ||
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 18796539 | ||
| Pubmed | 3.28e-04 | 14 | 67 | 2 | 19874786 | ||
| Pubmed | 3.71e-04 | 916 | 67 | 8 | 32203420 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 5.48e-04 | 18 | 67 | 2 | 12119179 | |
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 12799088 | ||
| Pubmed | 6.36e-04 | 202 | 67 | 4 | 24639526 | ||
| Pubmed | 8.24e-04 | 22 | 67 | 2 | 12812986 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 8.33e-04 | 95 | 67 | 3 | 29643511 | |
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 9.01e-04 | 23 | 67 | 2 | 14715245 | |
| Pubmed | 9.74e-04 | 1327 | 67 | 9 | 32694731 | ||
| Pubmed | OTUB1 modulates c-IAP1 stability to regulate signalling pathways. | 9.82e-04 | 24 | 67 | 2 | 23524849 | |
| Pubmed | 1.05e-03 | 103 | 67 | 3 | 10574462 | ||
| Pubmed | 1.05e-03 | 103 | 67 | 3 | 21706016 | ||
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.07e-03 | 25 | 67 | 2 | 8493579 | |
| Pubmed | Common variants at ten loci influence QT interval duration in the QTGEN Study. | 1.07e-03 | 25 | 67 | 2 | 19305408 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.08e-03 | 104 | 67 | 3 | 31240132 | |
| Pubmed | 1.14e-03 | 407 | 67 | 5 | 12693553 | ||
| Pubmed | Gene knockouts that cause female infertility: search for novel contraceptive targets. | 1.34e-03 | 28 | 67 | 2 | 15970507 | |
| Pubmed | 1.52e-03 | 1139 | 67 | 8 | 36417873 | ||
| Pubmed | 1.56e-03 | 118 | 67 | 3 | 21078624 | ||
| Pubmed | 1.64e-03 | 31 | 67 | 2 | 19690177 | ||
| Pubmed | Identification of Redox and Glucose-Dependent Txnip Protein Interactions. | 1.75e-03 | 32 | 67 | 2 | 27437069 | |
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 1.75e-03 | 32 | 67 | 2 | 37067297 | |
| Pubmed | 1.86e-03 | 33 | 67 | 2 | 19714462 | ||
| Cytoband | 15q21 | 1.14e-04 | 11 | 67 | 2 | 15q21 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.30e-05 | 206 | 46 | 6 | 682 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.32e-04 | 7 | 46 | 2 | 1113 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.30e-04 | 66 | 46 | 3 | 722 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#1_top-relative-expression-ranked_500 | 1.94e-05 | 52 | 65 | 4 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k1 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-Treg-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-08 | 190 | 67 | 7 | c3c7de22657a86495939456bc22eac61c93db8b2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-Treg|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-08 | 190 | 67 | 7 | 166119c037d80fee852567a9cc53c4143dd19037 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.07e-07 | 180 | 67 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 4.63e-07 | 193 | 67 | 6 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | severe_influenza-NK_CD56bright|World / disease group, cell group and cell class (v2) | 3.58e-06 | 154 | 67 | 5 | 187b9d4eb0e98c506034735601ead480ff00bd57 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.45e-06 | 161 | 67 | 5 | 2849fbc9611af208241b33da3cd18290aafe426b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.14e-06 | 172 | 67 | 5 | 9497948bbe53fb88c6ff6b347f743d456da587e5 | |
| ToppCell | Healthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.87e-06 | 176 | 67 | 5 | 7765a5b04ac117d525201f8eb08e1754e55942ff | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.06e-06 | 177 | 67 | 5 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 181 | 67 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 182 | 67 | 5 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.52e-06 | 184 | 67 | 5 | 5b4f18b26d03e8e5798cac70d124534749fc4cc0 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 8.75e-06 | 185 | 67 | 5 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 8.75e-06 | 185 | 67 | 5 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue | 9.45e-06 | 188 | 67 | 5 | 604f340052807bd902915eca942a97ccc36b42e0 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 9.45e-06 | 188 | 67 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-05 | 191 | 67 | 5 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-05 | 191 | 67 | 5 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 192 | 67 | 5 | 7dbe3117a0f58ff2e838963d49f788a59a4351d7 | |
| ToppCell | ILEUM-inflamed-(1)_Tregs|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.05e-05 | 192 | 67 | 5 | 1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 193 | 67 | 5 | 643f992dbce639e7d147924d8b8f455fcebf215a | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 193 | 67 | 5 | f7e4a390921780587b9bd084e495e646fa1ec74f | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 193 | 67 | 5 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 194 | 67 | 5 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | PCW_05-06-Endothelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 194 | 67 | 5 | 00291c62795a55a7e63b1db10c139d6a3298e55e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 194 | 67 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 194 | 67 | 5 | 32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 194 | 67 | 5 | eb279e0d922de921343f0ae032a809f837d915b3 | |
| ToppCell | PCW_13-14-Endothelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 196 | 67 | 5 | 7286de29a34e13834cd6347c67a1443897fa4ade | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 196 | 67 | 5 | c65b8c7ea34a21897c390e6fb42ee8ca41e9c976 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-05 | 196 | 67 | 5 | ecbc2baec21e85e6d8eac32d46f2c966fc35e223 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-05 | 196 | 67 | 5 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 196 | 67 | 5 | 0e8d649b50be2d707510b897bb97767b5847dff9 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 196 | 67 | 5 | 9ed96085f0acce07bf2f8d4cc212cc50e613be0c | |
| ToppCell | PCW_10-12-Endothelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 196 | 67 | 5 | 2c60dcf9132ee156f25b349e2ac5313709def4f6 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 1.16e-05 | 196 | 67 | 5 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 197 | 67 | 5 | a7922f65a8af4a773e4ce80114e4d895a594fa2f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_Tem|World / disease group, cell group and cell class (v2) | 1.19e-05 | 197 | 67 | 5 | bdd212ea869d7c96e2ab29fa5145417afe83f2a9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-05 | 197 | 67 | 5 | 7c9df6025b9d168bd6d041c6cff1e87e08b11847 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-05 | 197 | 67 | 5 | 54fb7197db3c0dc87a1114e1ab1d2bfafd564b35 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-05 | 198 | 67 | 5 | 03423d6c614440b9c738f75ac3f5a6941719a279 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 198 | 67 | 5 | 223c9986a213d8b22a348719c481b68b8f640f31 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 200 | 67 | 5 | a4c41509ca936e137230a6ae548c90f18a566d12 | |
| ToppCell | Cerebellum-Neuronal-Excitatory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.17e-05 | 128 | 67 | 4 | c30ba14320e9b98c9af9e4cd5a8c55380bb9ffa9 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Sorcs1_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.88e-05 | 47 | 67 | 3 | eef028d66c49406e71387e59bf7dddf5d5247472 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Sorcs1_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.88e-05 | 47 | 67 | 3 | 6420abf8a0094a1de6dea0670d5820b99edff78d | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.77e-05 | 145 | 67 | 4 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.73e-05 | 150 | 67 | 4 | 4f31867cb85253ff6d22f3b02ef972a42cb41123 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.73e-05 | 150 | 67 | 4 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.34e-05 | 153 | 67 | 4 | cda759ab83a271974651fe4faa21ed4f7ecbb3ae | |
| ToppCell | COVID-Treg-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 8.34e-05 | 153 | 67 | 4 | 47c649fd4231e507f2d4654ccac61faf21a04eff | |
| ToppCell | COVID-Treg|COVID / Condition, Cell_class and T cell subcluster | 8.99e-05 | 156 | 67 | 4 | a1dd61d4c9ed8f283f0fcbf875c5fd7807ca370d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.22e-05 | 157 | 67 | 4 | 0a552abfd139afc8516c38ca568f9922511dddce | |
| ToppCell | severe_influenza-NK_CD56bright|severe_influenza / disease group, cell group and cell class (v2) | 9.22e-05 | 157 | 67 | 4 | fabaf54429dd5a899f9192f0d42522109ca36b9b | |
| ToppCell | severe_COVID-19-MAIT|severe_COVID-19 / disease group, cell group and cell class (v2) | 9.22e-05 | 157 | 67 | 4 | 175f637e9707836bd63b5c2ccc9d4eb601c05b9e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.45e-05 | 158 | 67 | 4 | 2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.45e-05 | 158 | 67 | 4 | da060f5b61c7088f700d138b02ea596adacf7d60 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.45e-05 | 158 | 67 | 4 | 5775246e192629058ed89fb56031bdf4cbb9c15c | |
| ToppCell | Int-URO-Lymphocyte-T_NK-Treg|Int-URO / Disease, Lineage and Cell Type | 9.45e-05 | 158 | 67 | 4 | 457d64dceedb67bfff1303334cda1253a839b3d6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-05 | 160 | 67 | 4 | 50d4f867d021abcfeb49e6812bcfd5bb57466a31 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 160 | 67 | 4 | 6bafbe2b4b98bc088406a516d079093f89d9c344 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-05 | 160 | 67 | 4 | 0f15f895f11dcabb73df79b26bfc4947f38435a7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-05 | 160 | 67 | 4 | 7d004bfe42707605b3851cb2319126acda4d4802 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-Treg|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.04e-04 | 162 | 67 | 4 | 975d52e3cc101e7592425128e1099d30847a8a42 | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.04e-04 | 162 | 67 | 4 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-04 | 163 | 67 | 4 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-04 | 163 | 67 | 4 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-04 | 163 | 67 | 4 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-04 | 163 | 67 | 4 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | Influenza_Severe-CD4+_CTL|Influenza_Severe / Disease group and Cell class | 1.09e-04 | 164 | 67 | 4 | 9ffd40ae1f39290840bea79fa4e73cb7e009f310 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 166 | 67 | 4 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 167 | 67 | 4 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.17e-04 | 167 | 67 | 4 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 1.17e-04 | 167 | 67 | 4 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.20e-04 | 168 | 67 | 4 | b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 1.22e-04 | 169 | 67 | 4 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | IIF-Lymphocyte-T_NK-Treg|IIF / Disease, Lineage and Cell Type | 1.22e-04 | 169 | 67 | 4 | aac6ff89e0b3bc1f644e6cc6a696360659b254b5 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 1.22e-04 | 169 | 67 | 4 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 169 | 67 | 4 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 1.25e-04 | 170 | 67 | 4 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-04 | 171 | 67 | 4 | e1fe07652c10c37191d1471ddaea500f74269e0c | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 172 | 67 | 4 | 6379ae0aca9007c3a8a87e3330908fc90961ad3f | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2) | 1.34e-04 | 173 | 67 | 4 | b6615ff02f5017d7150b1e33b53f8c7a26081a0d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 67 | 4 | 7fb7bdf62563f2102fb38618b503eb2817b6594f | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-04 | 174 | 67 | 4 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-04 | 175 | 67 | 4 | 8269721389a3ce98681460e6393f2cff816eaa25 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-04 | 176 | 67 | 4 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-04 | 176 | 67 | 4 | 6b1cf1e98b4509e87f9eea827fa7090ce1e504f1 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 1.43e-04 | 176 | 67 | 4 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-04 | 177 | 67 | 4 | e1ba7e17af2c54d3c78cdf85882168c5b896e453 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 177 | 67 | 4 | bb496fbec7cacc52847abe2b2714249c47879763 | |
| ToppCell | (1)_T_regulatory|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.46e-04 | 177 | 67 | 4 | 5cda56b10df1ee8971ce8470d52062e01b703a4e | |
| ToppCell | CTRL-Lymphoid-T_cell_&_NK_cell|CTRL / Disease state, Lineage and Cell class | 1.46e-04 | 177 | 67 | 4 | e73d8e78a96b63e27a8a7694c62b3c44ec7ecfe6 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 178 | 67 | 4 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.49e-04 | 178 | 67 | 4 | 90dedb3cef9b01907b9f8eec64218d6d2072be1f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 178 | 67 | 4 | f94e306b9550f3d1b5de0bb806790c17823d439e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.49e-04 | 178 | 67 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.49e-04 | 178 | 67 | 4 | d6312286bf6cc5b107ccd7adb583d9667d4e1d21 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 178 | 67 | 4 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-04 | 179 | 67 | 4 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| Disease | multiple sclerosis | 2.98e-04 | 594 | 64 | 7 | MONDO_0005301 | |
| Disease | neutrophil percentage of leukocytes | 3.49e-04 | 610 | 64 | 7 | EFO_0007990 | |
| Disease | hair colour measurement | 3.67e-04 | 615 | 64 | 7 | EFO_0007822 | |
| Disease | banks of the superior temporal sulcus volume measurement | 6.17e-04 | 17 | 64 | 2 | EFO_0010286 | |
| Disease | Bone marrow hypocellularity | 6.93e-04 | 18 | 64 | 2 | C1855710 | |
| Disease | Pancytopenia | 1.46e-03 | 26 | 64 | 2 | C0030312 | |
| Disease | mammographic density percentage | 1.81e-03 | 29 | 64 | 2 | EFO_0006502 | |
| Disease | neuroblastoma | 2.07e-03 | 116 | 64 | 3 | EFO_0000621 | |
| Disease | neutrophil count | 2.85e-03 | 1382 | 64 | 9 | EFO_0004833 | |
| Disease | triglycerides in large LDL measurement | 3.95e-03 | 43 | 64 | 2 | EFO_0022319 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALLRVLQEDEEHWGS | 36 | Q2M3D2 | |
| RVWDLSDIDKDGHLD | 166 | Q9UBC2 | |
| ILLDILEHDWREAQD | 316 | Q9BWT7 | |
| LENLEDLFWELDRLD | 11 | P32302 | |
| GGDRLIHEQDLEWLQ | 71 | O43598 | |
| ELEDLEHLQLDFWRG | 41 | P15085 | |
| DHDWENLEKDLRLLI | 796 | Q7Z2Y8 | |
| DELELFHALEAWLGR | 226 | A6NE02 | |
| HRLDEDWDSALFAEL | 21 | P18850 | |
| PHFLLEDLLLNEWEA | 606 | Q7Z478 | |
| AEELGHEAFWEQELR | 166 | Q02833 | |
| VALLHEDRAEVWDLD | 256 | Q6P2E9 | |
| INLAEDVLAWEHERF | 361 | Q969V3 | |
| WILIHDRRDIFGNEI | 291 | P17735 | |
| NLHLEETLAEFWARL | 156 | P35052 | |
| HVEYEWRLLHEDLDE | 686 | O43150 | |
| AALRHGELELKEEWQ | 26 | Q7Z465 | |
| HQGILEELEERLSNW | 956 | Q6ZNL6 | |
| LDYNHEEWIELRLSL | 176 | O60229 | |
| DIVEDRLLVHFDNWD | 216 | Q8NA19 | |
| EDSFEGLVQLRHLWL | 146 | Q9BXB1 | |
| DRKERDLHEDLWFEL | 261 | Q9NQV6 | |
| FRLHDDQILEWCGED | 121 | O94886 | |
| DEEVQERLDHLLCWL | 96 | O77932 | |
| ELLLDHGVRVDVKDW | 246 | Q96T49 | |
| WIIIDRQAEDGHFLE | 226 | Q6ZMU1 | |
| FEDLWQRHLENGGDL | 151 | I3L3R5 | |
| DWLHLELEIQPEADA | 931 | O15360 | |
| HLEDWRGQLSELLND | 411 | Q6ZU35 | |
| ERERWQHLADLADFA | 1006 | O60266 | |
| EAREELLLHQSEWEG | 1371 | Q9C0D2 | |
| LDELDKDHLQLREAW | 356 | Q8WXH0 | |
| RDEGQLYHLLLEDFW | 26 | Q9H3E2 | |
| DDGWIFGERLHDQER | 646 | Q8N5V2 | |
| DERLDLDDGRWEDVH | 751 | Q6ZUM4 | |
| EGWHLFRFNREELLD | 676 | Q86VE3 | |
| EIHNDDGVWLRLNDE | 2506 | O75592 | |
| WEALHRELDSLNGEK | 76 | A8MT33 | |
| EQFLDDFIDLVIWGH | 231 | P49959 | |
| RLHEFLREAEDLQGW | 1731 | Q9NRC6 | |
| GIRLHWEDKYLNDLE | 891 | Q13733 | |
| FEVLERHTQWGLDLL | 11 | Q15642 | |
| WLRPAEEDHLEDSLE | 416 | Q6IBW4 | |
| RAWLDRHGNLDEAVE | 556 | Q96EP0 | |
| LEDSWRELIDGHEKL | 316 | O94827 | |
| ALEFLLWLLDRVHED | 186 | Q70EL4 | |
| EEWELLDDAQRLLYH | 61 | Q8TAW3 | |
| LIHILEEWFGVEQLE | 21 | Q96MH6 | |
| DERLDLQWSLEGHQL | 51 | Q9GZS3 | |
| LEELHGDANWGEDLR | 86 | Q9UH99 | |
| HEVLNGLLDRPDWEE | 251 | Q9NRA0 | |
| EWALGADEDFLLEHI | 691 | Q9Y2I1 | |
| EVHWLRDGQILELAD | 66 | P30530 | |
| DLHRLEWLIIEDNHL | 196 | Q9HBX9 | |
| HQFGADLDGLLDWLR | 776 | Q9H254 | |
| AHDLDDELAWVQERL | 1521 | Q9H254 | |
| IEHTLQWARDEFEGL | 641 | P22314 | |
| GNAELHEWEERRDAL | 926 | Q8IWR0 | |
| SQEEWGHLDEAQRLL | 21 | Q8IVP9 | |
| EALLGNRLDSHDWEK | 251 | Q5SXM2 | |
| EFLLWLLDRVHEDLN | 231 | Q70CQ4 | |
| LVLFLHDTELRQWEE | 26 | Q96GR4 | |
| HDTELRQWEEQGELL | 31 | Q96GR4 | |
| IFLDRRGDHEVEQWA | 366 | P21754 | |
| RWLLEDAEEFLAEGL | 11 | Q86WV1 | |
| LEQGDEPWREENEHL | 66 | Q14929 | |
| DLGDRLRDWFQLLHE | 206 | Q92563 | |
| RFLRNADDDEHEWIT | 141 | Q5VZ52 | |
| EDLEHLNEDGELWFA | 1126 | Q9NQX4 | |
| HLEGLINEWNLELED | 76 | Q9H1M0 |